Related by context. All words. (Click for frequent words.) 74 latent TB 69 LTBI 69 latent tuberculosis infection 66 latent tuberculosis 66 hepatitis B infection 66 latently infected 65 tuberculin skin testing 65 CMV infection 64 BRCA mutation 64 TB germ 64 MDR tuberculosis 64 familial pancreatic cancer 64 H. pylori 63 immunosuppressed 63 immunosuppressed patients 63 HCV infection 63 latent TB infections 63 chronic HBV infection 63 WNV infection 63 HCV infections 62 WNV infections 62 HBV infection 62 Genital herpes 62 H pylori 62 MYH9 gene 62 HCV infected 62 hepatitis C genotype 62 NOMID 62 latent infection 62 rhinovirus infection 62 asymptomatic carriers 62 chronic hepatitis cirrhosis 62 HCV antibody 61 BRAF mutation 61 pulmonary TB 61 Hepatitis B virus 61 seropositivity 61 immunocompetent 61 chlamydia infection 61 Chlamydia trachomatis 61 EBV infection 61 herpesviruses 61 narcolepsy cataplexy 61 varicella zoster virus VZV 60 Epstein Barr virus EBV 60 cervical HPV 60 C. diff infections 60 N. meningitidis 60 subclinical hyperthyroidism 60 S. aureus infections 60 H. pylori infection 60 invasive fungal infection 60 HIV HCV coinfected 60 VZV 60 ADPKD 60 S. aureus infection 60 Latent TB 60 antibody titer 60 CMV disease 60 poor metabolizers 60 sCJD 60 IgA deficiency 60 pneumococci 60 familial ALS 60 mutated virus 60 genital herpes infections 60 TB bacterium 60 chronically infected 60 Chlamydia pneumoniae 60 HNPCC 60 tuberculin skin test 60 serotype #A 60 causative organisms 60 multidrug resistant strains 60 MGUS 60 basal cell nevus syndrome 60 chronic HCV 60 P. vivax malaria 60 Hib disease 59 colorectal cancer CRC 59 TB bacilli 59 AAT deficiency 59 hepatitis C infection 59 herpes infection 59 elevated triglyceride levels 59 multidrug resistant 59 advanced neoplasia 59 BRCA mutations 59 rhinovirus infections 59 hepatitis C virus 59 pneumococcal infection 59 RSV infections 59 coagulation abnormalities 59 immunodeficient 59 super spreaders 59 CA MRSA infections 59 recurrent genital herpes 59 antiviral therapy 59 respiratory viral infections 59 genital HPV infections 59 HBV 59 postexposure prophylaxis 59 chronic hepatitis 59 M. bovis 59 HAV infection 59 chlamydial infections 59 Mantoux test 59 HBsAg 59 Multidrug resistant 59 simplex virus 59 prostate cancer CaP 59 candidemia 59 HSV1 59 corona virus 59 chlamydial infection 59 immuno suppressed 58 elevated CRP 58 NAFLD 58 genital HPV 58 pulmonary tuberculosis 58 sero positive 58 systemic lupus erythematosus SLE 58 XDR tuberculosis 58 isolated systolic hypertension 58 novel H#N# influenza 58 pneumococcal pneumonia 58 influenza A/H#N# virus 58 metastatic lung cancer 58 GABHS 58 ALI ARDS 58 HCV 58 TB MDR TB 58 adenomatous polyps 58 HER2 overexpression 58 serologic 58 meningococcal bacteria 58 MCAD deficiency 58 varicella infection 58 Cryptococcus neoformans 58 BCG vaccinated 58 TACI mutations 58 acute myelogenous leukemia AML 58 vWD 58 immunocompromised patients 58 enteroviruses 58 IgG antibodies 58 N. gonorrhoeae 58 herpes zoster vaccine 58 untreated celiac disease 58 herpes zoster virus 58 gastric adenocarcinoma 58 obstructive coronary artery 58 oesophageal adenocarcinoma 58 orchitis 58 immunologically matched 58 chronic HBV 58 HPV subtypes 58 GIST tumors 58 HIV infected 58 abnormal Pap smear 58 BMPR2 58 chronic HCV infection 58 causative organism 58 recurrent wheezing 58 Candida species 58 infecting organism 58 QuantiFERON 57 PTLD 57 LQTS 57 ASCUS 57 ApoE4 57 herpes zoster 57 S. aureus isolates 57 serologically 57 herpes zoster shingles 57 clade B 57 coinfected 57 chlamydial 57 NNRTI resistance 57 hereditary hemochromatosis 57 S. aureus bacteria 57 Salmonella typhi 57 HLA B# 57 hereditary predisposition 57 Glioblastoma Multiforme GBM 57 chronic periodontitis 57 systemic scleroderma 57 human metapneumovirus 57 Asymptomatic 57 Hepatitis B Virus 57 HIV serostatus 57 H5 viruses 57 Trichomonas vaginalis 57 staphylococcal infections 57 HBV vaccine 57 pneumococcal vaccination 57 Vesivirus 57 Staphylococcus aureus infections 57 Chlamydia infection 57 HPV infections 57 HbF 57 congenital CMV 57 eosinophilic pneumonia 57 S.aureus 57 H.I.V. 57 pharmacologic intervention 57 oncogenic HPV 57 untreated sleep apnea 57 metapneumovirus 57 genital HSV 57 C. trachomatis 57 ESBL producing E. coli 57 PPSV# 57 primary immunodeficiency PI 57 bacteraemia 57 S. suis 57 Hurthle cell 57 CP CPPS 57 Balamuthia 57 HIV seropositive 57 diabetes mellitus DM 57 Respiratory Syncytial Virus RSV 57 BRCA2 gene mutation 57 anti JCV antibodies 57 noroviruses 57 CDAD 57 T2DM 57 C. difficile infections 57 pandemic H#N# influenza 57 BRAF V# mutation 57 Helicobacter pylori H. pylori 57 curable cancers 57 pre cancerous polyps 57 breast cancer susceptibility genes 57 herpes simplex virus 57 Helicobacter pylori 57 hepatorenal syndrome 57 paralytic polio 57 M. pneumoniae 57 humoral responses 57 meningococcus 57 APOE e4 57 Nonalcoholic fatty liver 57 RLS sufferers 57 Li Fraumeni 57 asymptomatic 57 microscopic hematuria 57 seropositive 57 cervical neoplasia 57 BRCA2 mutation 57 fluoroquinolone resistance 57 intranasal vaccine 57 virus subtype 57 Shigella bacteria 57 acute rheumatic fever 57 hepatitis B HBV 57 type 1diabetes 57 TGFBR1 * 6A 57 multidrug resistance 56 viral subtypes 56 basal cell cancers 56 hepatitis B virus HBV 56 fluoroquinolone resistant 56 Recombinant interferon alpha 56 Chronic sinusitis 56 systolic dysfunction 56 CCR5 tropic 56 varices 56 hepatitis C HCV 56 EHEC infections 56 cytopathic 56 lymphogranuloma venereum 56 urethritis 56 coinfection 56 M. leprae 56 precancerous cervical lesions 56 Pulmonary arterial hypertension 56 immunodeficiency 56 medullary thyroid cancer 56 chronic hepatitis B. 56 rhinosinusitis 56 B streptococcal 56 V. vulnificus 56 renal cell carcinomas 56 hemolytic uremic syndrome HUS 56 lymphocytic choriomeningitis virus LCMV 56 P. knowlesi 56 neuroblastoma tumors 56 mycobacterium tuberculosis 56 Severe Primary IGFD 56 nonalcoholic steatohepatitis NASH 56 MRSA colonization 56 penicillin allergy 56 streptococcal infections 56 H Pylori 56 invasive meningococcal disease 56 dengue haemorrhagic fever DHF 56 germline mutations 56 toxoplasma 56 H. pylori infections 56 USA# strain 56 invasive aspergillosis 56 neutralizing antibodies 56 microalbuminuria 56 recurrent UTI 56 Squamous 56 combination antiretroviral therapy 56 T#I mutation 56 superinfection 56 dengue hemorrhagic fever 56 squamous cell lung cancer 56 receiving antiretroviral therapy 56 murine leukemia virus 56 diffuse gastric 56 oropharyngeal cancer 56 G6PD deficiency 56 antiplatelet medications 56 heavily pretreated 56 Candidiasis 56 T1DM 56 P. falciparum malaria 56 BRCA2 mutations 56 Vitamin B# deficiency 56 CCR5 receptor antagonist 56 primary immunodeficiencies 56 atherothrombotic disease 56 intestinal biopsy 56 MRSA isolates 56 latent tuberculosis TB 56 NPM1 mutation 56 pneumococcal infections 56 gallstone disease 56 S OIV 56 myeloproliferative neoplasms 56 dengue viruses 56 Aspergillus infections 56 SSc 56 multidrug resistant TB MDR 56 IgM antibodies 56 virus XMRV 56 zoster 56 vaccinees 56 eczema vaccinatum 56 Helicobacter 56 hypereosinophilic syndrome 56 Cytomegalovirus 56 disease vCJD 56 bloodborne 56 MRSA strains 56 Dengue virus 56 EGFR mutation 56 abnormal Pap smears 56 benign proliferative breast 56 Hepatitis B virus HBV 56 Pneumococcal pneumonia 56 varicella zoster virus 56 pancreatic adenocarcinoma 56 acid suppressive medication 56 precursor lesions 56 Staphylococcus aureus MRSA 56 gonococcal infections 56 Mycoplasma pneumoniae 56 A. fumigatus 56 hydroxyvitamin D levels 56 BRCA1 mutations 56 HPV genotypes 56 persistent wheezing 56 seroconverted 56 falciparum malaria 56 Pseudomonas aeruginosa infections 56 CMV retinitis 56 cTnT 56 trichomonas 56 ApoE4 gene 56 Rh positive 56 chorioamnionitis 56 acinetobacter 56 genital HPV infection 56 precancer 56 Haptoglobin 56 S aureus 56 periodontal pathogens 56 IgA antibodies 56 imatinib resistance 56 glaucoma sufferers 56 vancomycin resistant 56 Aortic stenosis 56 prion infection 56 C. jejuni 56 placental malaria 56 Adenoviruses usually cause 55 TB bacillus 55 dengue hemorrhagic fever DHF 55 chronic Hepatitis B 55 rheumatoid factor 55 minimally symptomatic 55 antimicrobial prophylaxis 55 HIV coinfected 55 virus HBV 55 Candida infection 55 diabetic kidney 55 malignant pleural mesothelioma 55 T. vaginalis 55 slow progressors 55 postoperative pulmonary 55 BRCA1 mutation 55 adenovirus infections 55 dysglycemia 55 XMRV infection 55 serogroup C 55 HER2 expression 55 HPAI H#N# 55 amebiasis 55 parainfluenza virus 55 chronic hepatitis B 55 neuroendocrine cancers 55 precancerous condition 55 invasive cervical cancer 55 C. difficile infection 55 cytomegalovirus retinitis 55 Acute myeloid leukemia 55 highly pathogenic H#N# 55 renal carcinoma 55 ELISpot 55 unruptured aneurysm 55 bronchogenic carcinoma 55 rotavirus diarrhea 55 Malignant gliomas 55 primary aldosteronism 55 multidrug resistant organisms 55 polysaccharide vaccines 55 Epstein Barr Virus EBV 55 KRAS mutations 55 DVT PE 55 EGFR mutations 55 HPV infection 55 HBeAg negative 55 mutated K ras 55 intravenous bisphosphonates 55 CHIKV 55 ofpatients 55 Helicobacter pylori infection 55 nutlin 3a 55 cytomegalovirus infection 55 pCR 55 pulmonary hypertension PH 55 Anopheles gambiae mosquitoes 55 dengue haemorrhagic fever 55 nonmelanoma skin cancers 55 venous blood clots 55 familial adenomatous polyposis 55 APOE ε4 55 primary immunodeficiency 55 familial hypercholesterolemia 55 tubercle bacillus 55 Neisseria gonorrhoeae 55 pharmacologic stress 55 disease 55 PCNSL 55 hepatitis B vaccination 55 resistant organisms 55 GRNOPC1 contains 55 RAS mutations 55 genital lesions 55 T SPOT.TB 55 mycobacterial infections 55 subclinical hypothyroidism 55 relapsed leukemia 55 SHPT 55 HIVAN 55 HLA genes 55 bacterial prostatitis 55 Chlamydia psittaci 55 ABCB1 55 lysosomal storage diseases 55 chronic bilirubin encephalopathy 55 thyroid nodules 55 antiviral prophylaxis 55 virologic failure 55 quinolone 55 autoantibodies 55 nontuberculous mycobacteria 55 immunosuppressive medications 55 VUR 55 immunocompromised individuals 55 H. pylori bacteria 55 micrometastases 55 HIV 55 simian foamy virus 55 HBV infections 55 postoperative delirium 55 KRAS mutation 55 NRTI resistance 55 familial dysautonomia 55 WNV encephalitis 55 anemia hemoglobin 55 Human Papillomavirus 55 Hepatocellular Carcinoma HCC 55 Neisseria 55 precancerous cervical 55 HCV antibodies 55 neuro invasive 55 infectious syphilis 55 hormone deprivation 55 seronegative 55 GBA mutations 55 enterovirus infection 55 K ras mutations 55 T. cruzi 55 Irritable bowel syndrome 55 CLL cells 55 CCR5 tropic HIV 55 Hib meningitis 55 immuno compromised 55 RMSF 55 Neisseria meningitidis bacteria 55 malaria endemic areas 55 EGFR mutation status 55 AIOD 55 NAbs 55 thyrotropin levels 55 HIB vaccine 55 receiving immunosuppressive therapy 55 rotaviruses 55 BCG vaccination 55 thrombocytopenic 55 transfusion transmitted 55 resistant TB 55 OSAHS 55 GRNOPC1 cells 55 CC genotype 55 falciparum 55 chronic hepatitis C. 55 human immunodeficiency virus 55 Fatty Liver Disease 55 virus RSV 55 allogeneic bone marrow 55 Helicobacter Pylori 55 nonmelanoma skin cancer 55 complete cytogenetic response 55 pleural mesothelioma 55 antibiotic methicillin 55 Borrelia 55 androgen deficiency 55 Cholangiocarcinoma 55 relapsing remitting MS RRMS 55 APOE4 55 tuberculosis TB 55 serum antibody 55 Cytomegalovirus CMV 54 postexposure 54 bacterium Mycobacterium tuberculosis 54 #q# deletion 54 IPAH 54 Enterococci 54 atopic 54 Chronic lymphocytic leukemia 54 invasive pneumococcal disease 54 cytomegalovirus CMV 54 diarrheal illness 54 abnormal pap smear 54 ε4 54 streptococcal 54 Lymphocytic 54 Listeria infections 54 gene APOE4 54 H#N# Swine flu 54 antibiotic resistant MRSA 54 gestational diabetes mellitus 54 curative therapy 54 Falciparum malaria 54 Unvaccinated 54 Thyroid nodules 54 acute humoral rejection 54 HIV uninfected 54 Bronchiolitis 54 genital ulcers 54 chronic rhinosinusitis 54 cholangiocarcinoma 54 H7 viruses 54 GnRH agonists 54 lymphatic filariasis 54 heterozygous FH 54 Vitamin D insufficiency 54 inherited predisposition 54 mesotheliomas 54 shiga toxin 54 ELISPOT 54 Regular checkups 54 sustained virologic response 54 upper gastrointestinal bleeding 54 PIDD 54 congenital CMV infection 54 Marburg haemorrhagic fever 54 MIF protein 54 neurologic complications 54 pandemic influenza virus 54 overt hypothyroidism 54 Prehypertension 54 GBM tumors 54 invasive carcinoma 54 etiologic agent 54 superantigens 54 pneumococcal meningitis 54 LCMV infection 54 severely immunocompromised 54 perioperative complications 54 trivalent inactivated influenza 54 LHON 54 HNSCC 54 iron overload 54 Hemochromatosis 54 broadly neutralizing 54 Uncontrolled hypertension 54 IUGR 54 empiric therapy 54 peritoneal cancer 54 recurrent glioblastoma multiforme 54 Genital Herpes 54 breast endometrial 54 atherothrombosis 54 metastatic neuroendocrine tumors 54 endocrine therapies 54 abnormal Pap test 54 Plasmodium falciparum malaria 54 abnormal mammogram 54 osteosarcomas 54 carotid stenosis 54 hypovitaminosis D 54 super infectors 54 atypical hyperplasia 54 basal cell carcinomas 54 Herpes simplex virus 54 MUC1 protein 54 Panton Valentine Leukocidin PVL 54 causal variants 54 severe congenital neutropenia 54 subtyped 54 AAT Deficiency 54 HBeAg positive patients 54 atypical ductal hyperplasia 54 Gleevec resistant 54 Hepatitis C virus HCV 54 feline immunodeficiency virus 54 C diff infection 54 sustained virological response 54 microvascular disease 54 histological subtype 54 chronic prostatitis 54 Hepatitis C Virus 54 S. maltophilia 54 bronchopulmonary dysplasia BPD 54 Extensively drug 54 enteroviral 54 pneumococcal serotypes 54 uveal melanoma 54 NNRTIs 54 C. difficile colitis 54 Human papillomavirus 54 ALT flares 54 serogroup 54 Simian Immunodeficiency Virus 54 Salmonella spp 54 advanced adenomas 54 gonococcal 54 Adenomas 54 cryptococcal meningitis 54 myeloid leukemia 54 PTEN mutations 54 ARVD 54 HBsAg positive 54 HIV TB coinfection 54 hepatitis B virus 54 ORMDL3 54 subclinical 54 Marburg virus infection 54 advanced adenoma 54 subclinical disease 54 HCV genotype 1 54 bacterial vaginosis BV 54 hemagglutination inhibition 54 prostate carcinoma 54 Opportunistic infections 54 invasive pneumococcal 54 anal HPV 54 smoldering myeloma 54 invasive MRSA infections 54 diastolic heart 54 paramyxoviruses 54 lichen planus 54 Thyroid disorders 54 arenavirus 54 HER2 positive cancers 54 relapsed MM 54 Norovirus infection 54 Influenza vaccination 54 lupus nephritis 54 nosocomial 54 disease NAFLD 54 T. gondii 54 peptide antigens 54 del 5q MDS 54 prion disease 54 cranial irradiation 54 aortic valve stenosis 54 sputum cultures 54 Leber congenital amaurosis LCA 54 BRAF V#E mutation 54 bacterial vaginosis 54 BRCA gene mutation 54 C difficile infection 54 temporal arteritis 54 non progressors 54 post thrombotic syndrome 54 PsA 54 cirrhosis liver failure 54 CCR5 delta# 54 genital ulcer disease 54 benign polyps 54 Hepatitis C virus 54 BRCA mutation carriers 54 FVIII inhibitors 54 pyridostigmine 54 Polycythemia vera 54 TB germs 54 S Typhi 54 metastatic malignant melanoma 54 null responder 54 commonly infect humans 54 P aeruginosa 54 intensive statin therapy 54 reinfection 54 Bronchiectasis 54 causes genital herpes 54 mitochondrial toxicity 54 Herpes zoster 54 infective endocarditis 54 Campylobacter infections 54 autoimmune thyroid 54 intracranial hemorrhage ICH 54 Enterobacteriaceae 54 Urinary tract infections UTIs 54 sentinel nodes 54 autoantibody 54 opportunistic pathogens 54 autoantibody positive 54 bacterium Neisseria meningitidis 54 polyomavirus nephropathy 54 parasite Trypanosoma cruzi 54 hemodialysis patients 54 CIN3 54 pilocytic astrocytomas 54 Antibiotic resistant infections 54 infective agent 54 avian influenza virus 54 superficial bladder cancer 54 GISTs 54 polyp recurrence 54 Variant Creutzfeldt Jakob Disease 54 HMPV 54 Salmonella Typhi 54 prostate adenocarcinoma 54 Bacille Calmette Guerin BCG 54 T#I [002] 54 prescribed statins 54 fetuin 54 unresectable stage 54 CMV infections 54 distal colon cancer 54 E. coli STEC 54 Staphylococcus aureus bacteria 54 adenovirus infection 54 refractory CML 54 cysticercosis 54 gemifloxacin 54 atopic disorders 54 malignant myeloma 54 Clostridium difficile infections 54 noninfectious 54 immunosuppressant therapy 54 radezolid 54 Bordetella pertussis 54 virus HCV infection 54 microdeletions 54 prostate specific 54 Intestinal parasites 54 nosocomial transmission 54 Gag polymorphisms 54 bowel cancers 54 cisplatin chemotherapy 54 acute respiratory tract infections 53 idiopathic pulmonary arterial hypertension 53 chemoprophylaxis 53 helicobacter pylori 53 recurrent VTE 53 carbapenem resistant 53 tuberculosis bacterium 53 CRKP 53 psoriatic arthritis PsA 53 cervical lesions 53 serum IgE 53 H#Y 53 HIV infection 53 therapeutic regimens 53 squamous cell cancer 53 cryptogenic 53 Celiac disease affects 53 inflammatory rheumatic 53 Myelodysplastic syndromes 53 KIF6 gene 53 coagulase negative staphylococci 53 genetic variants associated 53 GPC5 53 neuroblastomas 53 Bartonella species 53 EoE 53 mtDNA mutations 53 Genital HPV 53 severely immunosuppressed 53 Guerma 53 rifamycins 53 HPV# 53 influenza subtypes 53 immunocompromised 53 Strep infections 53 P vivax 53 JAK2 mutation 53 microscopic colitis 53 KRAS oncogene 53 Anaplasmosis 53 Sporadic CJD 53 Toxoplasmosis 53 Plaque psoriasis 53 Babesia 53 fructose intolerance 53 diagnose Alzheimer disease 53 colorectal liver metastases 53 asymptomatic bacteriuria 53 decompensated liver disease 53 Graves ophthalmopathy 53 severe rotavirus gastroenteritis 53 imipenem 53 WNv 53 thyrotropin 53 colorectal cancer 53 chronic rheumatic 53 LVNC 53 MCV4 53 abnormal vaginal bleeding 53 Canine influenza 53 glycated hemoglobin levels 53 colorectal carcinoma 53 multisymptom illness 53 M#V mutation 53 HIBM 53 genotypic resistance 53 Hepatitis E 53 nonalcoholic steatohepatitis 53 Swine flu viruses 53 heterosexually acquired 53 Mycobacterium avium 53 Tindamax R 53 Coxiella burnetii 53 haematopoietic 53 Staphylococcal infections 53 acute promyelocytic leukemia 53 aldosterone antagonist 53 acute febrile 53 serologic testing 53 Streptococcus 53 Iron deficiency anemia 53 Idiopathic Pulmonary Fibrosis IPF 53 colorectal adenoma 53 GBMs 53 pharyngeal cancer 53 juvenile idiopathic arthritis JIA 53 peginterferon 53 immune reconstitution syndrome 53 BCG vaccine 53 T2D 53 discontinued Viread 53 Irritable Bowel Syndrome IBS 53 liver transplant recipients 53 vCJD 53 Respiratory Virus 53 Ad5 immunity 53 WNV 53 troponin T 53 Chronic hepatitis B 53 severely immunocompromised patients 53 Waldenstrom macroglobulinemia 53 antibody titers 53 influenza 53 POAG 53 varicella chickenpox 53 parasitic worm infections 53 latently infected cells 53 polycystic ovary syndrome PCOS 53 seroprevalence 53 late onset hypogonadism 53 dentinal hypersensitivity 53 TMP SMX 53 diagnosed prenatally 53 babesiosis 53 hyperphenylalaninemia HPA due 53 Altastaph 53 beta catenin protein 53 Malignant Melanoma 53 enteric fever 53 Rh negative 53 influenza AH#N# 53 shorter telomere length 53 Rh factor 53 chickenpox virus 53 Clostridium difficile infection 53 pentoxifylline 53 MetS 53 hyperuricemia 53 Fanconi syndrome 53 resistant isolates 53 sputum smear 53 Klebsiella pneumoniae 53 screening colonoscopy 53 relapsing MS 53 nasopharyngeal cancer 53 gonococcal infection 53 Pneumococcal vaccines 53 multidrug resistant MDR 53 vivax 53 HBV genotype 53 RhD negative 53 coccidia 53 APTIVUS ritonavir 53 protease inhibitor mutations 53 MenB 53 calcium oxalate stones 53 M. catarrhalis 53 thrombophilia 53 MYH9 53 Pneumocystis carinii pneumonia 53 epithelial tumors 53 basal cell carcinoma BCC 53 Escherichia coli O# 53 CAG repeats 53 differentiated thyroid 53 V Leiden 53 Non Alcoholic Fatty 53 Infected Patients 53 deleterious mutation 53 Hashimoto thyroiditis 53 non metastatic osteosarcoma 53 vivax malaria 53 herpes simplex 53 M. genitalium 53 haematologic malignancies 53 Meningococcal Meningitis 53 abacavir Ziagen 53 antihypertensive drugs 53 tuberculosis 53 bacteriuria 53 pathogenic viruses 53 Typhi 53 Endometrial cancer 53 bronchopulmonary dysplasia 53 transfusion syndrome 53 S. aureus colonization 53 chlamydia sexually transmitted 53 Chest x rays 53 glioblastoma tumors 53 pertussis 53 asymptomatically 53 tuberculous 53 sickle cell disease 53 Chagas disease 53 Relapsing remitting MS 53 methicillin resistant S. aureus 53 Acute Myeloid Leukaemia AML 53 causative mutation 53 empiric treatment 53 Lung transplantation 53 elevated LDH 53 Shigella 53 Cognitive impairment 53 Chronic Myeloid Leukemia 53 hepatocellular carcinomas 53 hypersensitivity reaction 53 antiphospholipid antibodies 53 prediabetes 53 Chronic Heart Failure 53 myeloproliferative disorders 53 Influenza Type 53 Autoimmune diseases 53 renovascular hypertension 53 radioiodine therapy 53 mucosal immunity 53 seasonal influenza vaccination 53 C trachomatis 53 carcinoid tumors 53 Bcr Abl mutations